AU2012261883A1 - Lysyl oxidase-like 2 assay and methods of use thereof - Google Patents

Lysyl oxidase-like 2 assay and methods of use thereof Download PDF

Info

Publication number
AU2012261883A1
AU2012261883A1 AU2012261883A AU2012261883A AU2012261883A1 AU 2012261883 A1 AU2012261883 A1 AU 2012261883A1 AU 2012261883 A AU2012261883 A AU 2012261883A AU 2012261883 A AU2012261883 A AU 2012261883A AU 2012261883 A1 AU2012261883 A1 AU 2012261883A1
Authority
AU
Australia
Prior art keywords
loxl2
antibody
disease
individual
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012261883A
Other languages
English (en)
Inventor
Joanne I. Adamkewicz
Jeffrey D. Bornstein
Jason CHIEN
Xiaoming Li
Susan K. Lyman
Lixin Shao
Victoria Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Biologics Inc
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2012261883(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of AU2012261883A1 publication Critical patent/AU2012261883A1/en
Priority to AU2016244254A priority Critical patent/AU2016244254B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
AU2012261883A 2011-06-01 2012-06-01 Lysyl oxidase-like 2 assay and methods of use thereof Abandoned AU2012261883A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016244254A AU2016244254B2 (en) 2011-06-01 2016-10-12 Lysyl oxidase-like 2 assay and methods of use thereof

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US61/492,210 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US61/550,895 2011-10-24
US201161578813P 2011-12-21 2011-12-21
US61/578,813 2011-12-21
PCT/US2012/040585 WO2012167181A1 (en) 2011-06-01 2012-06-01 Lysyl oxidase-like 2 assay and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016244254A Division AU2016244254B2 (en) 2011-06-01 2016-10-12 Lysyl oxidase-like 2 assay and methods of use thereof

Publications (1)

Publication Number Publication Date
AU2012261883A1 true AU2012261883A1 (en) 2013-05-02

Family

ID=46208194

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2012261883A Abandoned AU2012261883A1 (en) 2011-06-01 2012-06-01 Lysyl oxidase-like 2 assay and methods of use thereof
AU2016244254A Ceased AU2016244254B2 (en) 2011-06-01 2016-10-12 Lysyl oxidase-like 2 assay and methods of use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2016244254A Ceased AU2016244254B2 (en) 2011-06-01 2016-10-12 Lysyl oxidase-like 2 assay and methods of use thereof

Country Status (25)

Country Link
US (3) US20140206017A1 (cg-RX-API-DMAC7.html)
EP (1) EP2714744A1 (cg-RX-API-DMAC7.html)
JP (3) JP2014523521A (cg-RX-API-DMAC7.html)
KR (1) KR20140048156A (cg-RX-API-DMAC7.html)
CN (1) CN103946241A (cg-RX-API-DMAC7.html)
AP (1) AP2013007285A0 (cg-RX-API-DMAC7.html)
AR (1) AR086657A1 (cg-RX-API-DMAC7.html)
AU (2) AU2012261883A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013030682A2 (cg-RX-API-DMAC7.html)
CA (1) CA2837534A1 (cg-RX-API-DMAC7.html)
CL (1) CL2013003445A1 (cg-RX-API-DMAC7.html)
CO (1) CO6940375A2 (cg-RX-API-DMAC7.html)
CR (1) CR20130657A (cg-RX-API-DMAC7.html)
EA (1) EA201391627A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP13013092A (cg-RX-API-DMAC7.html)
IL (1) IL229631A0 (cg-RX-API-DMAC7.html)
MA (1) MA35212B1 (cg-RX-API-DMAC7.html)
MD (1) MD20130098A2 (cg-RX-API-DMAC7.html)
MX (1) MX2013013905A (cg-RX-API-DMAC7.html)
PE (1) PE20141450A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013502490A1 (cg-RX-API-DMAC7.html)
TW (1) TW201319572A (cg-RX-API-DMAC7.html)
UY (1) UY34115A (cg-RX-API-DMAC7.html)
WO (1) WO2012167181A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201308812B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) * 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
CA2771702A1 (en) 2009-08-21 2011-02-24 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and loxl2
BR112012019693A2 (pt) 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
WO2014070939A1 (en) * 2012-10-30 2014-05-08 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
EA201692202A1 (ru) 2014-06-11 2017-06-30 Джилид Сайэнс, Инк. Способы лечения сердечно-сосудистых заболеваний
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
JP2019510752A (ja) 2016-03-04 2019-04-18 ギリアード サイエンシーズ, インコーポレイテッド オートタキシン阻害剤の組成物及び合剤
JP2019513737A (ja) 2016-04-08 2019-05-30 ギリアード サイエンシーズ, インコーポレイテッド がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
RU2012110580A (ru) * 2009-08-21 2013-09-27 Джилид Байолоджикс, Инк. Способы скрининга in vivo
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
US9556882B2 (en) * 2011-05-10 2017-01-31 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
MX2013013905A (es) 2014-05-14
US20170269085A1 (en) 2017-09-21
AR086657A1 (es) 2014-01-15
KR20140048156A (ko) 2014-04-23
JP2016164578A (ja) 2016-09-08
IL229631A0 (en) 2014-01-30
AU2016244254A1 (en) 2016-11-03
MD20130098A2 (ro) 2014-06-30
AU2016244254B2 (en) 2018-10-18
JP2014523521A (ja) 2014-09-11
NZ618682A (en) 2016-04-29
BR112013030682A2 (pt) 2016-12-06
UY34115A (es) 2013-01-03
WO2012167181A1 (en) 2012-12-06
CL2013003445A1 (es) 2014-07-25
AP2013007285A0 (en) 2013-11-30
ZA201308812B (en) 2014-08-27
JP2018049033A (ja) 2018-03-29
EA201391627A1 (ru) 2014-08-29
CR20130657A (es) 2014-05-16
US20120309020A1 (en) 2012-12-06
CO6940375A2 (es) 2014-05-09
PH12013502490A1 (en) 2014-01-20
MA35212B1 (fr) 2014-06-02
EP2714744A1 (en) 2014-04-09
CN103946241A (zh) 2014-07-23
TW201319572A (zh) 2013-05-16
US20140206017A1 (en) 2014-07-24
CA2837534A1 (en) 2012-12-06
PE20141450A1 (es) 2014-11-06
ECSP13013092A (es) 2014-08-29

Similar Documents

Publication Publication Date Title
AU2016244254B2 (en) Lysyl oxidase-like 2 assay and methods of use thereof
US20170327595A1 (en) Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
US20230288436A1 (en) Antibodies binding specifically to nt-probnp and use thereof
US20120301467A1 (en) Fas binding antibodies
JP7191813B2 (ja) 急性心不全に罹患している対象におけるうっ血を評価するためのアドレノメデュリン
JP2023515042A (ja) ショックの治療若しくは予防において使用するための抗アドレノメデュリン(ADM)抗体若しくは抗ADM抗体フラグメント又は抗ADM非Ig足場
JP2023518731A (ja) コロナウイルスに感染した患者におけるdpp3
JP2023516615A (ja) ショックを患っている患者におけるnt-adm抗体治療法ガイダンス、モニタリング、及び層別化のためのdpp3
CN108700586A (zh) 用于评估癌症发生的风险的组合物和方法
US20200041506A1 (en) Kit for rapid diagnosis of asthma or allergy disease
ES2846836T3 (es) Método para predecir la sensibilidad a una terapia combinada con lenvatinib y everolimus
NZ618682B2 (en) Lysyl oxidase-like 2 assay and methods of use thereof
JP2023518380A (ja) コロナウイルスに感染した患者におけるプロアドレノメデュリンまたはそのフラグメント、およびアドレノメデュリンに対する結合剤による治療
JP2023515985A (ja) ショック状態の患者の治療において使用するための抗アドレノメデュリン(adm)結合剤

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted